CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 9,640 shares (to pay taxes)
- 4 Shares withheld for taxes CBO & COO gave up 3,112 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 2,360 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Executive Officer acquired 17,750 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 37,818 shares (to pay taxes)
- 4 Shares withheld for taxes CBO & COO gave up 11,185 shares (to pay taxes)
- 4 Shares withheld for taxes Executive VP, Head of R&D gave up 12,607 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 6,303 shares (to pay taxes)
- 4 Exercise or conversion General Counsel and Secretary acquired 7,342 shares (option exercise)
Page 10 of 26 · 502 filings